TLPH Talphera Net earnings per share growth forecast for next year

TLPH (talphera.com) - company brandmark

Amid strict FDA and DEA oversight, coupled with protective patents on drug delivery systems, the expected EPS dynamics for the next period clearly demonstrate market sentiment for Talphera, Inc. (TLPH). The metric settled at -5.00. While the high scalability of these biotechnologies promises a future monopoly, the current trial stage precludes any pricing power until the drugs receive official validation.

TLPH - Talphera Inc Projected earnings per share increase next year over the range 02/21/2024 - 11/10/2026

Comprehensive metric breakdowns and analytics for talphera.com (TLPH)

- stock quotes and analyst forecast:
Stock Quotes Talphera Corp|TLPH - Analyst Consensus Forecast
- market capitalization data:
Market Value Talphera|TLPH - Company Buyout Price
- company book value details:
Accounting Value per Share Talphera|TLPH - Total Net Assets|Market Capitalization to Book Value Ratio talphera.com|TLPH - Company Total Assets
- debt and liquidity data:
Debt to Equity Talphera, Inc.|TLPH - Long-Term Debt to Equity|Short-Term Debt to Equity Talphera|TLPH - Company Aggregate Indebtedness|Debts to Book Capitalization Talphera|TLPH - Company Long-Term Loans and Borrowings|Company Short-Term Debts Talphera|Quick Liquidity talphera.com
- earnings and market ratios statistics:
TLPH - Final Profit|Projected Future Earnings Talphera, Inc.|TLPH - P/E Multiple|Projected Price to Earnings Talphera, Inc.|TLPH - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple Talphera|TLPH - Operating income before deduction of amortization|Earnings per share for the last twelve months Talphera|TLPH - Earnings per share for the last 12 months|Quarterly EPS earnings growth talphera.com|TLPH - Net earnings per share growth this year|Expected earnings per share growth for next year Talphera, Inc.
Summary company analytics:Talphera Corp, TLPH
Core merchandise of Talphera

To decouple fundamental stability from market volatility, it is necessary to analyze the expected year-over-year dynamics of net profit per share. This indicator measures the percentage change in projected EPS, allowing for an assessment of capital scaling rates and cost management efficiency. By examining the forward earnings per share growth forecast, an investor finds confirmation of the high therapeutic expertise and stable image of Talphera, Inc. (TLPH) within the pharmaceutical sector.

Competitor analysis for Talphera, Inc.

Expected earnings per share growth for next year GILD|Earnings growth forecast for next year cidara.com|Net earnings per share growth forecast for next year Novavax, Inc. (NVAX)|Consensus forecast of earnings per share growth for next year curevac.com|Valneva - Expected earnings per share growth for next year|Projected earnings per share increase next year VIR (Vir Biotechnology Inc)|SIGA Corp - Earnings growth forecast for next year|EBS - Earnings growth forecast for next year|Atea Pharmaceuticals (AVIR) - Net earnings per share growth forecast for next year|IVVD (Invivyd) - Net earnings per share growth forecast for next year|Net earnings per share growth forecast for next year Enanta Pharmaceuticals, Inc.|Inovio Pharmaceuticals, Inc. - Net earnings per share change forecast for next year|Earnings growth forecast for next year HLVX|KLRS (Kalaris Tx) - Expected earnings per share trend next year|Earnings growth forecast for next year DYAI (Dyadic International, Inc.)|NanoViricides Inc. (NNVC) - Expected net earnings per share growth next year|COCP - Net earnings per share growth forecast for next year|Expected earnings per share trend next year TRAW (Traws Pharma, Inc.)|DWTX: Earnings growth forecast for next year|Qualigen Corp (QLGN) - Earnings growth forecast for next year|Expected earnings per share growth for next year ALVR|VBIV: Expected earnings per share trend next year|Earnings growth forecast for next year VIRI|Consensus forecast of earnings per share growth for next year vaxart.com